Complexin-2 antibody
Principal name
Complexin-2 antibody
Alternative names for Complexin-2 antibody
Complexin II, Synaphin-1, CPLX2
Ncbi ID
NM_006650, NM_001008220, NP_006641, NP_001008221, NP_001008221.1, NM_009946, NM_053878
Available reactivities
Available hosts
Available applications
Paraffin Sections (P), Western blot / Immunoblot (WB)
Background of Complexin-2 antibody
- Kit Component:
- - KN210806G1, CPLX2 gRNA vector 1 in pCas-Guide vector
- KN210806G2, CPLX2 gRNA vector 2 in pCas-Guide vector
- KN210806D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
"Early changes in Huntington's disease patient brains involve alterations in cytoskeletal and synaptic elements." DiProspero N.A., Chen E.-Y., Charles V., Plomann M., Kordower J.H., Tagle D.A. J. Neurocytol. 33:517-533(2004) [PubMed: 15906159]
Human Hippocampus; CPLX2 antibody - N-terminal region (ARP52225_P050) in Human Hippocampus cells using Immunohistochemistry
Human Liver; WB Suggested Anti-CPLX2 Antibody Titration: 0.2-1 ug/ml. Positive Control: Human Liver; CPLX2 antibody - N-terminal region (ARP52225_P050) in Human Liver cells using Western Blot
WB Suggested Anti-CPLX2 Antibody Titration: 0.2-1 ug/ml; Positive Control: Human Liver
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP310806 | Complexin-2 (transcript variant 1) |
||||
| Recombinant protein of human complexin 2 (CPLX2), transcript variant 1 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP321947 | Complexin-2 (transcript variant 2) |
||||
| Recombinant protein of human complexin 2 (CPLX2), transcript variant 2 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP710112 | Complexin-2 (full length, C-term DDK tag, transcript variant 1) |
||||
| Recombinant protein of human human complexin 2 (CPLX2), transcript variant 1, full length, with C-terminal DDK tag, expressed in sf9 cells | |||||
 |
Human | > 80 % Preparation: . Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
SF9 cells |
20 µg /
€411.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY423397 | CPLX2 overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR202037L2V | Lenti ORF particles, Cplx2 (GFP-tagged ORF) - Rat complexin 2 (Cplx2), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| RR202037L1V | Lenti ORF particles, Cplx2 (Myc-DDK-tagged ORF) - Rat complexin 2 (Cplx2), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
